Original research article| Volume 99, ISSUE 1, P32-35, January 2019

Medicaid and receipt of interval postpartum long-acting reversible contraception



      We sought to evaluate the impact of insurance type on receipt of an interval postpartum LARC, controlling for demographic and clinical factors.

      Study design

      This is a retrospective cohort study of 1072 women with a documented plan of LARC for contraception at time of postpartum discharge. This is a secondary analysis of 8654 women who delivered at 20 weeks or beyond from January 1, 2012, through December 31, 2014, at an urban teaching hospital in Ohio. LARC receipt within 90 days of delivery, time to receipt, and rate of subsequent pregnancy after non-receipt were compared between women with Medicaid and women with private insurance. Postplacental LARC was not available at the time of study completion.


      One hundred eighty-seven of 822 Medicaid-insured and 43 of 131 privately insured women received a LARC postpartum (22.7% vs 32.8%, P=.02). In multivariable analysis, private insurance status was not significantly associated with LARC receipt (OR 1.29, 95% C.I. 0.83–1.99) though adequate prenatal care was (OR 2.33, 95% C.I. 1.42–4.00). Of women who wanted but did not receive a LARC, 208 of 635 (32.8%) Medicaid patients and 19 of 88 (21.6%) privately insured patients became pregnant within 1 year (P=.02).


      Differences in receipt of interval postpartum LARC were not significant between women with Medicaid insurance versus private insurance after adjusting for clinical and demographic factors. Adequate prenatal care was associated with LARC receipt. Medicaid patients who did not receive a LARC were more likely to become pregnant within one year of delivery than those with private insurance.


      While insurance-related barriers have been reduced given recent policy changes, access to care remains an important determinant of postpartum LARC provision and subsequent unintended pregnancy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Finer L.B.
        • Zolna M.R.
        Declines in unintended pregnancy in the United States, 2008–2011.
        N Engl J Med. 2016; 374: 843-852
        • Hanley G.E.
        • Hutcheon J.A.
        • Kinniburgh B.A.
        • Lee L.
        Interpregnancy interval and adverse pregnancy outcomes: an analysis of successive pregnancies.
        Obstet Gynecol. 2017; 129: 408-415
        • Shree R.
        • Cuaghey A.B.
        • Chandrasekaran S.
        Short interpregnancy interval increases the risk of preterm premature rupture of membranes and early delivery.
        J Matern Fetal Neonatal Med. 2017; 2: 1-17
        • Jansa V.
        • Blickstein I.
        • Lucovnik M.
        • Fabjan-Vodusek V.
        • Verdenik I.
        • Tul N.
        The impact of inter-pregnancy interval on subsequent risk of preterm birth.
        J Matern Fetal Neonatal Med. 2017; 11: 1-7
        • Kavanaugh M.L.
        • Jerman J.
        • Finer L.B.
        Changes in use of long-acting reversible contraceptive methods among US women, 2009-2012.
        Obstet Gynecol. 2015; 126: 917-927
        • Law A.
        • Pilon D.
        • Lynen R.
        • Laliberte F.
        • Gozalo L.
        • Lefebvre P.
        • et al.
        Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
        Reprod Health. 2016; 13: 96-107
        • Brunson M.R.
        • Klein D.A.
        • Olsen C.H.
        • Weir L.F.
        • Roberts T.A.
        Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
        Am J Obstet Gynecol. 2017; 217: 55e1-9
        • Thiel de Bocanegra H.
        • Chang R.
        • Howell M.
        • Darney P.
        Interpregnancy intervals: impact of postpartum contraceptive effectiveness and coverage.
        Am J Obstet Gynecol. 2014; 210: 311e1
        • Higgins T.M.
        • Dougherty A.K.
        • Badger G.J.
        • Heil S.H.
        Comparing long-acting reversible contraception insertion rates in women with Medicaid vs. private insurance in a clinic with a two-visit protocol.
        Contraception. 2018; 97: 76-78
        • Branum A.M.
        • Jones J.
        Trends in long-acting reversible contraception use among U.S. women aged 15-44.
        NCHS Data Brief. 2015;
        • White K.
        • Potter J.E.
        • Hopkins K.
        • Grossman D.
        Variation in postpartum contraceptive method use: Results from the pregnancy risk assessment monitoring system (PRAMS).
        Contraception. 2014; 89: 57-62
        • Arora K.S.
        • Wilkinson B.W.
        • Verbus E.
        • Montague M.
        • Morris J.
        • Ascha M.
        • et al.
        Disparities in postpartum sterilization fulfillment rates.
        Contraception. 2018; 97: 559-564
        • R Core Team
        R: A language and environment for statistical computing.
        R Foundation for Statistical Computing
        Vienna, Austria
        Date: 2017
        • Tomlin K.
        • Bambulas T.
        • Sutton M.
        • Pazdernik V.
        • Coonrod D.V.
        Motivational interviewing to promote long-acting reversible contraception in postpartum teenagers.
        J Pediatr Adolesc Gynecol. 2017; 30: 383-388
        • Woo I.
        • Seifert S.
        • Hendricks D.
        • Jamshidi R.M.
        • Burke A.E.
        • Fox M.C.
        Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
        Contraception. 2015; 92: 532-535
        • Moniz M.H.
        • Dalton V.K.
        • Davis M.M.
        • Forman J.
        • Iott B.
        • Landgraf J.
        • et al.
        Characterization of Medicaid policy for immediate postpartum contraception.
        Contraception. 2015; 92: 523-531
        • Harney C.
        • Dude A.
        • Haider S.
        Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
        Contraception. 2017; 95: 245-250
        • Moniz M.H.
        • Chang T.
        • Heisler M.
        • Admon L.
        • Gebremariam A.
        • Galton V.K.
        • et al.
        Inpatient postpartum long-acting reversible contraception and sterilization in the United States, 2008-2013.
        Obstetet Gynecol. 2017; 129: 1078-1085
        • Zerden M.L.
        • Tang J.H.
        • Stuart G.S.
        • Norton D.R.
        • Verbiest S.B.
        • Brody S.
        Barriers to receiving long-acting reversible contraception in the postpartum period.
        Women Health Issues. 2015; 25: 616-621
        • Thompson K.M.J.
        • Rocca C.H.
        • Stern L.
        • Morfesis J.
        • Goodman S.
        • Steinauer J.
        • et al.
        Training contraceptive providers to offer intrauterine devices and implants in contraceptive care: A cluster randomized trial.
        Am J Obstet Gynecol. 2018; 218: 597.e1-597.e7